HOOKIPA Pharma Inc.

1.52
-0.01 (-0.65%)
At close: Mar 03, 2025, 11:38 AM

HOOKIPA Pharma Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income n/a -81.58M -64.92M -75.67M -44.08M -43.04M -16.24M -12.72M
Depreciation & Amortization n/a 3.55M 3.6M 4.64M 4.15M 1.44M 640K 398K
Stock-Based Compensation n/a 2.35M 5.04M 7.64M 8.66M 5.57M 867K 770K
Other Working Capital n/a -4.62M 38.45M 1.42M 511K -4.44M 8.59M 859K
Other Non-Cash Items -76.98M 12.83M 160K 1.23M 53K 1.68M 7K -45K
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital n/a 5.33M 36.11M -3.86M -8.12M -7.38M -275K -313K
Operating Cash Flow -76.98M -57.52M -20M -66.02M -39.34M -41.73M -15M -11.91M
Capital Expenditures n/a -4.16M -5.02M -12.58M -2.37M -2M -2.15M -1.3M
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -194K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -194K -4.16M -5.02M -12.58M -2.37M -2M -2.15M -1.3M
Debt Repayment n/a -1.75M -2.85M -438K -1.42M -2.28M 425K 747K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -1.28M 18.53M 29.43M n/a 32.2M 37.27M 12.89M 116.29M
Financial Cash Flow -1.28M 65.67M 72.27M -235K 73.42M 109.75M 6.87M 58.89M
Net Cash Flow -78.45M 4.08M 46.53M -76.27M 29.6M 65M -12.78M 48.18M
Free Cash Flow -76.98M -61.68M -25.01M -78.6M -41.71M -43.73M -17.15M -13.21M